Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients

Journal of Hypertension

Volumn 17, Issue 12, 1999, Pages 1751-1758

  Zoccali, Carmine ^a,d   Mallamaci, Francesca ^a   Tripepi, Giovanni ^a   Benedetto, Frank A ^c   Cottini, Emilio ^b   Giacone, Giuseppe ^b   Malatino, Lorenzo ^b  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Ospedale Morelli   (Italy)

^d CNR   (Italy)

Author keywords

24 h ambulatory blood pressure monitoring; Chronic renal failure; Dialysis; Hypertension; Left ventricular hypertrophy

Indexed keywords

CHOLESTEROL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENDER; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UREMIA; VARIANCE;

EID: 0032762470     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917120-00013     Document Type: Article

References (51)

1. Average T, Giles M, Tomson CV, Raine AE. Gender differences in mediators of left ventricular hypertrophy in dialysis patients. Clin Nephrol 1998; 49:107-112.
2. Nagahara T, Ishigami T, Sano T, Ikoda Y, Hibi K, Uneda S, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients. Jpn Heart J 1997; 38:821-830.
3. Raj DS, D'Mello S, Somiah S, Sheeba SD, Mani K. Left ventricular morphology in chronic renal failure by ochocardiography. Renal Fail 1997; 19:799-806.
4. Savage T, Fabbian F, Giles M, Tomson CR, Raine AE, Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant 1997; 12:2308-2311.
5. Neves PL, Silva AP, Bernardo I, Elderly patients in chronic hemodialysis: risk factors for left ventricular hypertrophy. Am J Kidney Dis 1997; 30:224-228.
6. Washio M, Okuda S, Mizoue T, Kiyama S, Ando T, Sanai T, et al. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients. Clin Nephrol 1997; 47:362-366.
7. Conlon PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ. Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 1996; 7:2658-2663.
8. de Lima JJ, Abensur H, Krieger EM, Pileggi F. Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients. J Hypertens 1996, 14:1019-24.
9. Roithinger FX, Punzengruber C, Wallner M, Berent R, Prischl FC, Kramar R, et al. Comparison between ambulatory 24-hour blood pressure measurement and occasional blood pressure measurement in hemodialysis patients with left heart hypertrophy. Wien Klin Wochenschr 1996; 108:358-362.
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardio: myopathy, J Am Soc Nephrol 1995; 5:2024-2031.
11. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24:768-776.
12. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4:1486-1490.
13. Kooman JP, Leunissen KM. Cardiovascular aspects in renal disease. Curr Opin Nephrol Hypertens 1993; 2:791-797.
14. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int Suppl 1993; 41 :S42-S49.
15. Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttmann RO. Left ventricular hypertrophy in end-stage renal disease. Nephron 1988; 48:107-115.
16. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50:600-608.
17. Erturk S, Ertug AE, Atos K, Duman N, Asian SM, Nergisoglu G, et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant 1996; 11:2050-2054.
18. Townsend RR, Ford V. Ambulatory blood pressure monitoring: coming of age in nephrology. J Am Soc Nepbrol 1998; 7:2279-2287.
19. Mansoor GA, White WB. Ambulatory monitoring is a useful clinical tool in nephrology. Am J Kidney Dis 1997; 30.591-664.
20. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379-1385.
21. Foley RN, Parfrey PS. Risk factors for cardiac morbidity and mortality in dialysis patients. Curr Opin Nephrol Hypertens 1994; 3:608-614.
22. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla O, Molinari S. Prolonged therapy with ace inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 1997; 30:659-664.
23. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44:881-886.
24. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ace inhibition and calcium channel blockade. Circulation 1994; 90:2786-2796.
25. Suzuki H, Schaefer L, Ling H, Schaefer RM, Dammrich J, Teschner M, Heidland, A. Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ace inhibitor administration: potential role of lysosomal proteinases. Am J Nephrol 1995; 15:129-136.
26. Mancia G, Ulian L, Parati G, Trazzi S. Increase in blood pressure reproducibility by repeated semi-automatic blood pressure measurements in the clinic environment. J Hypertens 1994; 12 (4):469-473.
27. Fagard RH, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 29:22-29.
28. Parati G, Bosi S, Castellano M, Cristofari M, Di Rienzo G, Germano S, et al. Guidelines for 24h non-invasive ambulatory monitoring. Report from a working group of the Italian Society of Hypertension. High Blood Pressure 1995; 4:168-174.
29. Sahn DJ, Demaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the Amorical Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic mesurements. Circulation 1978; 58:1072-1083.
30. Deverelix B, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek, N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
31. Savage DD, Garrison RJ, Kannel WB. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 1987; 75 (Suppl. 1):1-26.
32. Staessen JA, Bieniaszowski L, O'Brien E, Gosse P, Hayashi H, Imai Y, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997; 29:30-39.
33. Hirsch RP, Riegelman RK. Statistical operations. Cambridge, MA: Blackwell; 1996. pp. 369-402.
34. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310,.
35. Dahan M, Siohan P, Viron B, Michel C, Paillole C, Gourgon R, et al. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: an echocardiographic study. Am J Kidney Dis 1997; 30:780-785.
36. Vlahakos DV, Hahalis G, Vassilakos P, Marathias KP, Geroulanos S. Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients. J Am Soc Nephrol 1997; 8:1764-1770.
37. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P. Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45:104-110.
38. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 1997; 12:2301-2307.
39. Elisaf M, Pappas H, Kalaitzidis R, Katopodis K, Theodorou J, Siamopoulos KG. Ambulatory blood pressure monitoring in hemodialysis patients. J Hum Hypertens 1996; 10 (Suppl. 3):S43-S47.
40. Amar J, Chamontin B, Vernier I, Lenfant V, Conte J, Salvador M. Variabilite de la pression arterielle, rythme circadien et distensibilite arterielle chez l'hemodialyse. Arch Mal Coeur Vaiss 1994; 87:921-924.
41. Rosansky SJ, Johnson KL, Hutchinson C, Erdel S. Blood pressure changes during daytime sleep and comparison of daytime and nighttime sleep-related blood pressure changes in patients with chronic renal failuro. J Am Soc Nephrol 1993; 4:1172-1177.
42. Baumgart P, Walger P, Gemen S, von Eiff M, Raidt H, Rahn KH. Blood pressure elevation during the night in chronic renal failure, homodialysis and after renal transplantation. Nephron 1991; 57:293-298.
43. Goldsmith DJ, Covic AC, Venning MC, Ackrill P. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis 1997; 29:593-600.
44. Luik AJ, Struijk DG, Gladziwa U, von Olden RW, von Hooff JP, de Leeuw PW, et al. Diurnal blood-pressure variations in haemodialysis and Capd patients. Nephrol Dial Transplant 1994; 9:1616-1621.
45. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 1998; 53:1078-1084.
46. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and clinical valuo of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998; 16:733-738.
47. The Renal Association. Treatment of adult patients with renal failure, 2nd edition, London: Royal College of Physicians of London; 1997, p. 26.
48. Commissione qualità delle prestazioni sanitarie in Nefrologia. Qualità ed accreditamento in Nefrologia. Giornale Ital Nefrol 1996; 13:427-432.
49. Parfrey PS, Foley RN, Harnett DJ, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11:1277-1285.
50. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cosaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95:1464-1470.
51. Mancia G, Omboni S, Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens Suppl 1997; 15:343-350.